Facet browsing currently unavailable
Page 10 of 2497 results
Sort by: relevance publication year
Targeting the Wnt signaling pathway in colorectal cancer JOURNAL ARTICLE published 2 April 2016 in Expert Opinion on Therapeutic Targets |
ADAM10 as a therapeutic target for brain diseases: from developmental disorders to Alzheimer’s disease JOURNAL ARTICLE published 2 November 2017 in Expert Opinion on Therapeutic Targets Research funded by Alzheimer’s Association (NIRP-14-304969) | ADR program r6esearch fellowship (A2014314F) | Progetto di Ricerca di Interesse Nazionale (PRIN2015N4FKJ4) | Università degli Studi di Milano-Bicocca (PSR2015-1716GRACA02_05_M) |
MAPKs: new targets for neurodegeneration JOURNAL ARTICLE published April 2003 in Expert Opinion on Therapeutic Targets |
Dickkopf-1 as a potential therapeutic target in Paget's disease of bone JOURNAL ARTICLE published February 2010 in Expert Opinion on Therapeutic Targets |
Chromatin modification and muscle differentiation JOURNAL ARTICLE published December 2006 in Expert Opinion on Therapeutic Targets |
Targeting the CTLA-4/B7 axes in glioblastoma: preclinical evidence and clinical interventions JOURNAL ARTICLE published 2 November 2022 in Expert Opinion on Therapeutic Targets Research funded by Tabriz University of Medical Sciences (68136 and 68137) |
Understanding the role of galectins toward influenza A virus infection JOURNAL ARTICLE published 3 October 2023 in Expert Opinion on Therapeutic Targets Research funded by Kaohsiung Medical University Research Foundation (KMU-M108006) | Academia and Industry Collaboration Project of Kaohsiung Medical University (#KMU-S111019) |
Advances in cerebellar disorders: pre-clinical models, therapeutic targets, and challenges JOURNAL ARTICLE published 3 October 2023 in Expert Opinion on Therapeutic Targets |
Decoding the expression pattern of MUC3A in gastric adenocarcinoma: unveiling the key to successful immunotherapy JOURNAL ARTICLE published 2 December 2023 in Expert Opinion on Therapeutic Targets Research funded by Tehran University of Medical Sciences (40230-37-03-97) |
ADAM33: a novel therapeutic target for asthma JOURNAL ARTICLE published August 2003 in Expert Opinion on Therapeutic Targets |
Calcium channelopathies in neurodegenerative disorder: an untold story of RyR and SERCA JOURNAL ARTICLE published 2 November 2023 in Expert Opinion on Therapeutic Targets |
Interleukin-18 in cancer immunology and immunotherapy JOURNAL ARTICLE published 2 November 2023 in Expert Opinion on Therapeutic Targets Research funded by Ministry of Economy (MINECO SAF2014-52361-R and SAF 2017-83267-C2-1 R MC) |
Tolperisone induces UPR-mediated tumor inhibition and synergizes with proteasome inhibitor and immunotherapy by targeting LSD1 JOURNAL ARTICLE published 2 September 2023 in Expert Opinion on Therapeutic Targets Research funded by National Natural Science Foundation of China (82072949) | Nature Science Basic Research Program of Shaanxi (2023-JC-QN-0985) |
Lysyl Oxidase Isoforms and Potential Therapeutic Opportunities for Fibrosis and Cancer JOURNAL ARTICLE published 2 August 2016 in Expert Opinion on Therapeutic Targets Research funded by National Institute of Dental and Craniofacial Research (R21DE023973) | Pharmaxis Corporation, Sydney, NSW, Australia (Research Contract) |
Targets to treat androgen excess in polycystic ovary syndrome JOURNAL ARTICLE published 2 November 2015 in Expert Opinion on Therapeutic Targets |
Therapy innovation for the treatment of pancreatic neuroendocrine tumors JOURNAL ARTICLE published April 2012 in Expert Opinion on Therapeutic Targets |
Hepatocellular carcinoma treatment over sorafenib: epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel? JOURNAL ARTICLE published 2 December 2015 in Expert Opinion on Therapeutic Targets |
Targeting the PI3K and MAPK pathways to treat Kaposi’s sarcoma-associated herpes virus infection and pathogenesis JOURNAL ARTICLE published May 2007 in Expert Opinion on Therapeutic Targets |
Targeting oxidative stress in cancer JOURNAL ARTICLE published November 2010 in Expert Opinion on Therapeutic Targets |
FGF2: a novel druggable target for glioblastoma? JOURNAL ARTICLE published 2 April 2020 in Expert Opinion on Therapeutic Targets |